Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer

Clinical trial NCT07641036 · RECRUITING

Trial details

NCT number: NCT07641036
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cholangiocarcinoma Intrahepatic Cholangiocarcinoma Extrahepatic Cholangiocarcinoma Gallbladder Carcinoma Biliary Tract Cancer

Start date: 2026-03-02
Primary completion: 2027-03-14
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.